Metastasis suppressors: a paradigm shift in cancer biology
Cancer Metastasis Rev
.
2023 Dec;42(4):1057-1059.
doi: 10.1007/s10555-023-10130-1.
Author
Danny R Welch
1
2
3
4
Affiliations
1
Departments of Cancer Biology, The University of Kansas, Medical Center, Kansas City, KS, 66160, USA. dwelch@kumc.edu.
2
Pathology & Laboratory Medicine, The University of Kansas, Medical Center, Kansas City, KS, 66160, USA. dwelch@kumc.edu.
3
Internal Medicine - Hematology/Oncology, The University of Kansas, Medical Center, Kansas City, KS, 66160, USA. dwelch@kumc.edu.
4
The University of Kansas Cancer Center, The University of Kansas, Medical Center, Kansas City, KS, 66160, USA. dwelch@kumc.edu.
PMID:
37535138
PMCID:
PMC10772737
(available on
2024-12-01
)
DOI:
10.1007/s10555-023-10130-1
No abstract available
Publication types
Editorial
MeSH terms
Biology
Humans
Neoplasm Metastasis
Neoplasms* / genetics
Neoplasms* / pathology
Signal Transduction*
Tumor Suppressor Proteins
Substances
Tumor Suppressor Proteins
Grants and funding
P30 CA168524/CA/NCI NIH HHS/United States
R01 CA087728/CA/NCI NIH HHS/United States
R01 CA134981/CA/NCI NIH HHS/United States
R21 CA277516/CA/NCI NIH HHS/United States